Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial…
By A. Lucci, L. Mccall, P. Beitsch, Pat W. Whitworth, D. Reintgen, P. Blumencranz, A. Leitch, S. Saha, K. Hunt, A. Giuliano. Journal of Clinical Oncology, 2007
796 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology, Surgery
View Paper: https://www.semanticscholar.org/paper/4768e1671dd7c7837c37e1a431285ee8cb9de4f7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Oncology
Citations in the corpus
- Locoregional Recurrence after Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial (2010, methodology): “A number of randomized prospective trials have demonstrated that short- and long-term morbidity is lessened after SLND compared with ALND.(9,23) Therefore, if SLND could achieve locoregional control as effectively as ALND without an adverse effect on survival, it would be the preferable procedure.”
- Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. (2008, background): “3%), but the sentinel node procedure was also associated with lower morbidity and improved quality of life when compared with complete lymphadenectomy.(19-23) Studies in vulvar cancer in which sentinel node detection was followed by inguinofemoral lymphadenectomy suggest that the sentinel node proce”
- NCCN Guidelines Insights: Breast Cancer, Version 1.2017. (2017, methodology): “R trial; (2) an AI for 2 to 3 years (category 1) followed by tamoxifen to complete 5 years of endocrine therapy (category 1); (3) tamoxifen for 2 to 3 years followed by one of the following options: an AI to complete 5 years of adjuvant endocrine therapy (category 1) or 5 years of AI therapy (catego”
- Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. (2014, background): “It was statistically significantly higher starting at 12 months, although not at 6 months or by arm measurement.(26) There was statistically significantly higher axillary seroma and parethesia in the immediate ALND arm (P .”
- Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. (2013, background): “7 months: 4/30 (13%)¶ ·· Level III-2 Lucci et al (2007);71 USA 891 newly diagnosed patients (T stage T1 or T2 recruited; N0, M0) 445 SLND+ALND (usual), 446 SLND alone Newly-diagnosed Arm circumferences; subjective (risk factors) >2 cm; patient self-report or physician diagnosis (risk factors) 6…”